Showing results (671-680 of 870) with videos related to

Sort By:
Pageof 87
The American Journal of the Medical Sciences|July 6, 2022
Satisfaction with modes of telemedicine delivery during COVID-19: A randomized, single-blind, parallel group, noninferiority trialMaria I Danila, Dongmei Sun, Lesley E Jackson, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosisÖzgür Yaldizli, Varun Sethi, Matteo Pardini, et al.
Neurology|January 21, 2021
Long-term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple SclerosisGiacomo Boffa, Luca Massacesi, Matilde Inglese, et al.
Neurology|September 14, 2019
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosingLana Zhovtis Ryerson, John Foley, Ih Chang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2021
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's diseaseFederico Massa, Andrea Chincarini, Matteo Bauckneht, et al.
Multiple Sclerosis and Related Disorders|October 15, 2019
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disordersGiovanni Novi, Francesca Bovis, Marco Capobianco, et al.
Neuromuscular Disorders : NMD|March 29, 2013
Early neurodevelopmental assessment in Duchenne muscular dystrophyMarika Pane, Roberta Scalise, Angela Berardinelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 25, 2020
Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's DiseaseAmy W Amara, Kimberly H Wood, Allen Joop, et al.
The Lancet. Neurology|July 21, 2023
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trialNir Giladi, Roy N Alcalay, Gary Cutter, et al.
Annals of Clinical and Translational Neurology|March 22, 2018
Brain atrophy and disability worsening in primary progressive multiple sclerosis: insights from the INFORMS studyDavid H Miller, Fred D Lublin, Maria Pia Sormani, et al.
Pageof 87